Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer (Q36670959)
Jump to navigation
Jump to search
scientific article published on 17 January 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer |
scientific article published on 17 January 2012 |
Statements
Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer (English)
Sharon O'Toole
Sine Phelan
Barbara McGrogan
Aoife Maguire
Anthony O'Grady
Aloysius McGoldrick
Donal Brennan
17 January 2012
1 reference